ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Dongdaemun Body Sculpting & Liposuction Cost Comparison Vs. USA Guide Released

Lydian Cosmetic Surgery Clinic releases a guide comparing body sculpting and liposuction costs in Dongdaemun, South Korea versus USA, showing potential savings of 40-65% for American patients seeking affordable cosmetic procedures abroad.

-- The new guide caters to the needs of "medical tourists", or rather, those who are interested in traveling abroad to access high-quality, affordable medical care. As the recently published information highlights, cosmetic procedures are particularly popular among these tourists, given that most US insurance providers do not cover elective surgeries of this type, leading many to look overseas for cost-effective alternatives.

More information is available at https://www.lydianclinic.com/blog/mommy-makeover-cost-korea-vs-usa-2/

South Korea has established itself as a global hub for plastic and cosmetic surgery, with industry statistics confirming substantial financial advantages for international patients. For example, liposuction in the United States costs between $4,000-$7,000 per area, while the same procedure (multi-area) in South Korea starts at $3,000, representing significant reductions in cost without a corresponding drop in quality, the guide explains.

The bulk of the new guidance focuses specifically on "Mommy Makeovers"—procedures designed to remove excess body fat through liposuction and other similar procedures—which have become especially popular among mothers who may be struggling to lose pregnancy weight. These procedures may also target the breasts and backside, and are highly customizable based on the needs of the individual.

As the clinic explains, even after accounting for international flights and accommodations, patients traveling to Korea for these cosmetic procedures are likely to realize significant net savings compared to domestic treatment costs. The guide clarifies that total expenditure, including travel logistics, remains lower than USA-only pricing, removing the primary objection to seeking care abroad.

The Lydian Clinic, located in Seoul, has performed over 20,000 operations across 23 years of clinical practice, establishing a track record of expertise and patient satisfaction. Dr. Abraham An, the clinic's founder and lead surgeon, brings extensive experience in body contouring and has developed proprietary techniques for precision sculpting with minimal scarring.

Those interested in finding out more about the services available through the clinic, or in accessing the full pricing guide, should visit https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89178566

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.81
+3.38 (1.48%)
AAPL  271.95
+0.98 (0.36%)
AMD  214.52
-0.43 (-0.20%)
BAC  56.15
+0.27 (0.47%)
GOOG  315.56
+4.23 (1.36%)
META  664.40
+2.90 (0.44%)
MSFT  486.79
+1.87 (0.39%)
NVDA  188.48
+4.79 (2.61%)
ORCL  194.40
-3.98 (-2.00%)
TSLA  484.27
-4.46 (-0.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.